Cargando…

Evolution of multiple cell clones over a 29-year period of a CLL patient

Chronic lymphocytic leukaemia (CLL) is a frequent B-cell malignancy, characterized by recurrent somatic chromosome alterations and a low level of point mutations. Here we present single-nucleotide polymorphism microarray analyses of a single CLL patient over 29 years of observation and treatment, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhikun, Goldin, Lynn, Liu, Shiping, Wu, Liang, Zhou, Weiyin, Lou, Hong, Yu, Qichao, Tsang, Shirley X., Jiang, Miaomiao, Li, Fuqiang, McMaster, MaryLou, Li, Yang, Lin, Xinxin, Wang, Zhifeng, Xu, Liqin, Marti, Gerald, Li, Guibo, Wu, Kui, Yeager, Meredith, Yang, Huanming, Xu, Xun, Chanock, Stephen J., Li, Bo, Hou, Yong, Caporaso, Neil, Dean, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171825/
https://www.ncbi.nlm.nih.gov/pubmed/27982015
http://dx.doi.org/10.1038/ncomms13765
_version_ 1782484019597803520
author Zhao, Zhikun
Goldin, Lynn
Liu, Shiping
Wu, Liang
Zhou, Weiyin
Lou, Hong
Yu, Qichao
Tsang, Shirley X.
Jiang, Miaomiao
Li, Fuqiang
McMaster, MaryLou
Li, Yang
Lin, Xinxin
Wang, Zhifeng
Xu, Liqin
Marti, Gerald
Li, Guibo
Wu, Kui
Yeager, Meredith
Yang, Huanming
Xu, Xun
Chanock, Stephen J.
Li, Bo
Hou, Yong
Caporaso, Neil
Dean, Michael
author_facet Zhao, Zhikun
Goldin, Lynn
Liu, Shiping
Wu, Liang
Zhou, Weiyin
Lou, Hong
Yu, Qichao
Tsang, Shirley X.
Jiang, Miaomiao
Li, Fuqiang
McMaster, MaryLou
Li, Yang
Lin, Xinxin
Wang, Zhifeng
Xu, Liqin
Marti, Gerald
Li, Guibo
Wu, Kui
Yeager, Meredith
Yang, Huanming
Xu, Xun
Chanock, Stephen J.
Li, Bo
Hou, Yong
Caporaso, Neil
Dean, Michael
author_sort Zhao, Zhikun
collection PubMed
description Chronic lymphocytic leukaemia (CLL) is a frequent B-cell malignancy, characterized by recurrent somatic chromosome alterations and a low level of point mutations. Here we present single-nucleotide polymorphism microarray analyses of a single CLL patient over 29 years of observation and treatment, and transcriptome and whole-genome sequencing at selected time points. We identify chromosome alterations 13q14−, 6q− and 12q+ in early cell clones, elimination of clonal populations following therapy, and subsequent appearance of a clone containing trisomy 12 and chromosome 10 copy-neutral loss of heterogeneity that marks a major population dominant at death. Serial single-cell RNA sequencing reveals an expression pattern with high FOS, JUN and KLF4 at disease acceleration, which resolves following therapy, but reoccurs following relapse and death. Transcriptome evolution indicates complex changes in expression occur over time. In conclusion, CLL can evolve gradually during indolent phases, and undergo rapid changes following therapy.
format Online
Article
Text
id pubmed-5171825
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51718252016-12-23 Evolution of multiple cell clones over a 29-year period of a CLL patient Zhao, Zhikun Goldin, Lynn Liu, Shiping Wu, Liang Zhou, Weiyin Lou, Hong Yu, Qichao Tsang, Shirley X. Jiang, Miaomiao Li, Fuqiang McMaster, MaryLou Li, Yang Lin, Xinxin Wang, Zhifeng Xu, Liqin Marti, Gerald Li, Guibo Wu, Kui Yeager, Meredith Yang, Huanming Xu, Xun Chanock, Stephen J. Li, Bo Hou, Yong Caporaso, Neil Dean, Michael Nat Commun Article Chronic lymphocytic leukaemia (CLL) is a frequent B-cell malignancy, characterized by recurrent somatic chromosome alterations and a low level of point mutations. Here we present single-nucleotide polymorphism microarray analyses of a single CLL patient over 29 years of observation and treatment, and transcriptome and whole-genome sequencing at selected time points. We identify chromosome alterations 13q14−, 6q− and 12q+ in early cell clones, elimination of clonal populations following therapy, and subsequent appearance of a clone containing trisomy 12 and chromosome 10 copy-neutral loss of heterogeneity that marks a major population dominant at death. Serial single-cell RNA sequencing reveals an expression pattern with high FOS, JUN and KLF4 at disease acceleration, which resolves following therapy, but reoccurs following relapse and death. Transcriptome evolution indicates complex changes in expression occur over time. In conclusion, CLL can evolve gradually during indolent phases, and undergo rapid changes following therapy. Nature Publishing Group 2016-12-16 /pmc/articles/PMC5171825/ /pubmed/27982015 http://dx.doi.org/10.1038/ncomms13765 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Zhao, Zhikun
Goldin, Lynn
Liu, Shiping
Wu, Liang
Zhou, Weiyin
Lou, Hong
Yu, Qichao
Tsang, Shirley X.
Jiang, Miaomiao
Li, Fuqiang
McMaster, MaryLou
Li, Yang
Lin, Xinxin
Wang, Zhifeng
Xu, Liqin
Marti, Gerald
Li, Guibo
Wu, Kui
Yeager, Meredith
Yang, Huanming
Xu, Xun
Chanock, Stephen J.
Li, Bo
Hou, Yong
Caporaso, Neil
Dean, Michael
Evolution of multiple cell clones over a 29-year period of a CLL patient
title Evolution of multiple cell clones over a 29-year period of a CLL patient
title_full Evolution of multiple cell clones over a 29-year period of a CLL patient
title_fullStr Evolution of multiple cell clones over a 29-year period of a CLL patient
title_full_unstemmed Evolution of multiple cell clones over a 29-year period of a CLL patient
title_short Evolution of multiple cell clones over a 29-year period of a CLL patient
title_sort evolution of multiple cell clones over a 29-year period of a cll patient
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171825/
https://www.ncbi.nlm.nih.gov/pubmed/27982015
http://dx.doi.org/10.1038/ncomms13765
work_keys_str_mv AT zhaozhikun evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT goldinlynn evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT liushiping evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT wuliang evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT zhouweiyin evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT louhong evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT yuqichao evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT tsangshirleyx evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT jiangmiaomiao evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT lifuqiang evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT mcmastermarylou evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT liyang evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT linxinxin evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT wangzhifeng evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT xuliqin evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT martigerald evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT liguibo evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT wukui evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT yeagermeredith evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT yanghuanming evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT xuxun evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT chanockstephenj evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT libo evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT houyong evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT caporasoneil evolutionofmultiplecellclonesovera29yearperiodofacllpatient
AT deanmichael evolutionofmultiplecellclonesovera29yearperiodofacllpatient